Total Returns (Price + Dividend) 
Neptune Wellness Solutions, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
Is Neptune Wellness Solutions, Inc. technically bullish or bearish?
As of 19 August 2025, the technical trend for Neptune Wellness Solutions, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed signals across different indicators. The MACD is mildly bullish on both weekly and monthly time frames, while the moving averages indicate a mildly bearish stance on the daily chart. The KST shows a mildly bullish trend on both weekly and monthly periods, but the RSI and Bollinger Bands are signaling sideways movement. Additionally, the OBV is mildly bullish on the monthly timeframe. In terms of performance, the stock has significantly outperformed the S&P 500 over the past week and month, with returns of 99.33% and 113.57%, respectively, compared to the S&P 500's 1.05% and 2.33%. However, longer-term returns over 3, 5, and 10 years are severely negative, indicating a substantial decline relative to the benchmark....
Read MoreIs Neptune Wellness Solutions, Inc. overvalued or undervalued?
As of 8 July 2024, the valuation grade for Neptune Wellness Solutions, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its valuation outlook. The company appears to be overvalued given its current financial metrics, particularly with a P/E ratio of -0.0027 and an EV to EBITDA ratio of -0.5617, both of which suggest a lack of profitability and negative enterprise value relative to earnings. Additionally, the ROE stands at an impressive 172.33%, but this is misleading due to the negative capital employed. In comparison with peers, Cidara Therapeutics, Inc. has a P/E of -13.4584 and an EV to EBITDA of -7.9458, while MIRA Pharmaceuticals, Inc. shows an EV to EBITDA of -2.7591. These figures highlight that Neptune's valuation metrics are significantly worse than those of its peers. Despite a remarkable recent stock performance, with a 1-week return of 99.33% compared to ...
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Foreign Institutions
Held in 0 Schemes (0%)
Held by 74 Foreign Institutions (6.05%)
Quarterly Results Snapshot (Consolidated) - Dec'23 - QoQ
QoQ Growth in quarter ended Dec 2023 is -12.64% vs -17.92% in Sep 2023
QoQ Growth in quarter ended Dec 2023 is -262.26% vs 45.92% in Sep 2023
Annual Results Snapshot (Consolidated) - Mar'23
YoY Growth in year ended Mar 2023 is 7.79% vs 37.85% in Mar 2022
YoY Growth in year ended Mar 2023 is -5.21% vs 33.80% in Mar 2022






